drugset / Trial / NCT02181426
Dose Response of Ketorolac in Knee Arthroscopy
RandomizedParallel-groupDouble-blindTreatment
Summary
Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.
Timeline
- Start
- 2012-03
- Primary completion
- 2016-12-15
- Completion
- 2016-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 7.5 mg | — |
| Comparator | Ketorolac | Other / unclassified | 15 mg | — |
| Comparator | Ketorolac | Other / unclassified | 30 mg | — |
Indications
No indication recorded.